These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7838898

  • 1. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
    Brambilla F, Perna G, Garberi A, Nobile P, Bellodi L.
    Psychoneuroendocrinology; 1995; 20(1):1-9. PubMed ID: 7838898
    [Abstract] [Full Text] [Related]

  • 2. Alpha 2-adrenergic receptor sensitivity in panic disorder: II. Cortisol response to clonidine stimulation in panic disorder.
    Brambilla F, Bellodi L, Arancio C, Nobile P, Perna G.
    Psychoneuroendocrinology; 1995; 20(1):11-9. PubMed ID: 7838899
    [Abstract] [Full Text] [Related]

  • 3. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation.
    Brambilla F, Ferrari E, Cavagnini F, Invitti C, Zanoboni A, Massironi R, Catalano M, Cocchi D, Müller EE.
    Biol Psychiatry; 1989 Feb 01; 25(3):256-64. PubMed ID: 2536561
    [Abstract] [Full Text] [Related]

  • 4. Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. Growth hormone response to clonidine stimulation.
    Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F.
    Psychiatry Res; 1997 Mar 24; 69(2-3):155-62. PubMed ID: 9109183
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Biol Psychiatry; 1995 Sep 01; 38(5):325-9. PubMed ID: 7495927
    [Abstract] [Full Text] [Related]

  • 6. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
    Tancer ME, Stein MB, Black B, Uhde TW.
    Am J Psychiatry; 1993 Feb 01; 150(2):336-7. PubMed ID: 8422091
    [Abstract] [Full Text] [Related]

  • 7. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM.
    Neuropsychopharmacology; 1992 Feb 01; 6(2):101-18. PubMed ID: 1610485
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J, Iglesias P, Sastre J, Méndez J, Selgas R, Gómez-Pan A.
    Nephron; 1996 Feb 01; 74(3):548-54. PubMed ID: 8938679
    [Abstract] [Full Text] [Related]

  • 9. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives.
    Cameron OG, Smith CB, Nesse RM, Hill EM, Hollingsworth PJ, Abelson JA, Hariharan M, Curtis GC.
    Psychosom Med; 1996 Feb 01; 58(4):289-301. PubMed ID: 8827791
    [Abstract] [Full Text] [Related]

  • 10. Psychoimmunoendocrine aspects of panic disorder.
    Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P.
    Neuropsychobiology; 1992 Feb 01; 26(1-2):12-22. PubMed ID: 1335559
    [Abstract] [Full Text] [Related]

  • 11. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC.
    Biol Psychiatry; 1992 Jul 01; 32(1):18-25. PubMed ID: 1391293
    [Abstract] [Full Text] [Related]

  • 12. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Pharmacopsychiatry; 1995 May 01; 28(3):80-3. PubMed ID: 7568369
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone (GH) responses to GH-releasing hormone in depression: correlation with GH release following clonidine.
    Lesch KP, Laux G, Erb A, Pfüller H, Beckmann H.
    Psychiatry Res; 1988 Sep 01; 25(3):301-10. PubMed ID: 3141943
    [Abstract] [Full Text] [Related]

  • 14. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Rapaport MH, Risch SC, Gillin JC, Golshan S, Janowsky DS.
    Am J Psychiatry; 1989 Jan 01; 146(1):92-5. PubMed ID: 2492166
    [Abstract] [Full Text] [Related]

  • 15. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug 01; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
    Tancer ME, Stein MB, Uhde TW.
    Biol Psychiatry; 1993 Nov 01; 34(9):591-5. PubMed ID: 8292687
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone responses to growth hormone-releasing hormone, clonidine and insulin-induced hypoglycemia in normal weight bulimic women.
    Coiro V, Capretti L, Volpi R, d'Amato L, Marchesi C, De Ferri A, Rossi G, Bianconi L, Marcato A, Chiodera P.
    Neuropsychobiology; 1990 Nov 01; 23(1):8-14. PubMed ID: 2126361
    [Abstract] [Full Text] [Related]

  • 18. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P, Knip M, Lautala P, Leppäluoto J.
    J Clin Endocrinol Metab; 1988 Oct 01; 67(4):845-9. PubMed ID: 3138280
    [Abstract] [Full Text] [Related]

  • 19. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD, Papp LA, Martinez J, Pine D, Rosenblum LA, Cooper T, Liebowitz MR, Gorman JM.
    Am J Psychiatry; 1995 Apr 01; 152(4):619-22. PubMed ID: 7694915
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy.
    Brambilla F, Bellodi L, Perna G.
    Psychiatry Res; 1999 Dec 13; 89(1):21-7. PubMed ID: 10643874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.